Robertson, J. F., Evans, A., Henschen, S., Kirwan, C. C., Jahan, A., Kenny, L. M., Dixon, J. M., Schmid, P., Kothari, A., Mohamed, O., Fasching, P. A., Cheung, K. L., Wuerstlein, R., Carroll, D., Klinowska, T., Lindemann, J. P., MacDonald, A., Mather, R., Maudsley, R., Moschetta, M., …Harbeck, N. (2020). A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2- Primary Breast Cancer. Clinical Cancer Research, 26(16), 4242-4249. https://doi.org/10.1158/1078-0432.CCR-19-3387